B. Wiman

4.5k total citations
68 papers, 3.8k citations indexed

About

B. Wiman is a scholar working on Cancer Research, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, B. Wiman has authored 68 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Cancer Research, 37 papers in Hematology and 23 papers in Pulmonary and Respiratory Medicine. Recurrent topics in B. Wiman's work include Protease and Inhibitor Mechanisms (41 papers), Blood Coagulation and Thrombosis Mechanisms (34 papers) and Blood properties and coagulation (23 papers). B. Wiman is often cited by papers focused on Protease and Inhibitor Mechanisms (41 papers), Blood Coagulation and Thrombosis Mechanisms (34 papers) and Blood properties and coagulation (23 papers). B. Wiman collaborates with scholars based in Sweden, Belgium and United Kingdom. B. Wiman's co-authors include Joanna Chmielewska, D Collen, Anders Hamsten, Désiré Collen, Mats Rånby, Sally J. Dawson, Steve E. Humphries, H.R. Lijnen, Adriano Henney and Sam Schulman and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Biochemical Journal.

In The Last Decade

B. Wiman

68 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Wiman Sweden 31 1.8k 1.8k 1.1k 540 509 68 3.8k
Victor Gurewich United States 32 1.5k 0.8× 1.0k 0.6× 1.0k 0.9× 559 1.0× 864 1.7× 144 4.0k
Francisco España Spain 42 2.3k 1.3× 1.1k 0.6× 890 0.8× 768 1.4× 819 1.6× 177 5.2k
Bradford S. Schwartz United States 20 837 0.5× 585 0.3× 494 0.4× 917 1.7× 319 0.6× 50 3.1k
H. L. Nossel United States 29 1.8k 1.0× 296 0.2× 1.4k 1.2× 388 0.7× 550 1.1× 71 3.5k
Jørgen Gram Denmark 27 761 0.4× 319 0.2× 709 0.6× 228 0.4× 589 1.2× 167 2.8k
Neal D. Tolley United States 23 1.6k 0.9× 606 0.3× 379 0.3× 1.5k 2.8× 605 1.2× 35 4.3k
R Bach United States 33 2.4k 1.3× 337 0.2× 578 0.5× 864 1.6× 334 0.7× 64 4.2k
Laurent O. Mosnier United States 38 3.4k 1.9× 495 0.3× 541 0.5× 821 1.5× 760 1.5× 93 5.2k
Ian MacGregor United Kingdom 26 781 0.4× 366 0.2× 431 0.4× 712 1.3× 245 0.5× 88 2.2k
G. P. McNicol United Kingdom 28 1.0k 0.6× 230 0.1× 603 0.5× 256 0.5× 486 1.0× 126 2.9k

Countries citing papers authored by B. Wiman

Since Specialization
Citations

This map shows the geographic impact of B. Wiman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Wiman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Wiman more than expected).

Fields of papers citing papers by B. Wiman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Wiman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Wiman. The network helps show where B. Wiman may publish in the future.

Co-authorship network of co-authors of B. Wiman

This figure shows the co-authorship network connecting the top 25 collaborators of B. Wiman. A scholar is included among the top collaborators of B. Wiman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Wiman. B. Wiman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wiman, B., et al.. (2006). Low PAI-1 activity in relation to the risk for perioperative bleeding complications in transurethral resection of the prostate. Thrombosis Research. 119(6). 715–721. 11 indexed citations
2.
Wiman, B., Per Lindmarker, Margareta Sten-Linder, et al.. (2005). Evaluation of low PAI‐1 activity as a risk factor for hemorrhagic diathesis. Journal of Thrombosis and Haemostasis. 4(1). 201–208. 38 indexed citations
3.
Leander, Karin, B. Wiman, Johan Hallqvist, Gary W. Falk, & Ulf dé Fairé. (2002). The G-455A polymorphism of the fibrinogen Bbeta-gene relates to plasma fibrinogen in male cases, but does not interact with environmental factors in causing myocardial infarction in either men or women : Journal of Internal Medicine. Journal of Internal Medicine. 252(4). 5 indexed citations
4.
Leander, Karin, B. Wiman, Johan Hallqvist, Gunnar Falk, & Ulf dé Fairé. (2002). The G‐455A polymorphism of the fibrinogen BΒ‐gene relates to plasma fibrinogen in male cases, but does not interact with environmental factors in causing myocardial infarction in either men or women. Journal of Internal Medicine. 252(4). 332–341. 25 indexed citations
5.
Wiman, B., Tomas Andersson, Johan Hallqvist, et al.. (2000). Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study : Arteriosclerosis, Thrombosis, and Vascular Biology. Arteriosclerosis Thrombosis and Vascular Biology. 20(8). 12 indexed citations
6.
Falk, Gunnar, Maria Sartori, G Patrassi, et al.. (1997). Identification of an 18 basepair deletion in the PAI-1 gene promoter region in a family with thrombotic disease. Fibrinolysis & proteolysis. 11(5-6). 239–244. 1 indexed citations
7.
Held, Claes, Paul Hjemdahl, Nina Rehnqvist, et al.. (1997). Haemostatic markers, inflammatory parameters and lipids in male and female patients in the Angina Prognosis Study In Stockholm (APSIS). A comparison with healthy controls. Journal of Internal Medicine. 241(1). 59–69. 35 indexed citations
8.
Nordenhem, A. & B. Wiman. (1997). Plasminogen activator inhibitor-1 (PAI-1) content in platelets from healthy individuals genotyped for the 4G/5G polymorphism in the PAI-1 gene. Scandinavian Journal of Clinical and Laboratory Investigation. 57(5). 453–461. 17 indexed citations
9.
Schulman, Sam, et al.. (1996). The Significance of Hypofibrinolysis for the Risk of Recurrence of Venous Thromboembolism. Thrombosis and Haemostasis. 75(4). 607–611. 50 indexed citations
10.
Declerck, Paul, I. Juhan‐Vague, Jordi Félez, & B. Wiman. (1994). Pathophysiology of fibrinolysis. Journal of Internal Medicine. 236(4). 425–432. 35 indexed citations
11.
Bredbacka, Sixten, Margareta Blombäck, B. Wiman, & H. Pelzer. (1993). Laboratory methods for detecting disseminated intravascular coagulation (DIC): new aspects. Acta Anaesthesiologica Scandinavica. 37(2). 125–130. 42 indexed citations
12.
Sigurðardóttir, Ólöf & B. Wiman. (1992). Studies on the interaction between plasminogen activator inhibitor-1 and vitronectin. Fibrinolysis and Proteolysis. 6(1). 27–32. 10 indexed citations
13.
Thomas, Angela, Sally J. Dawson, Anne Marie Lane, et al.. (1992). Possibilities of DNA Analysis for the Detection of Predisposition to Thrombotic Disease. Annals of the New York Academy of Sciences. 667(1). 332–342. 4 indexed citations
14.
Schulman, Sam, Hans Johnsson, & B. Wiman. (1989). Acute Effects with Reference to Thrombogenicity and Liver Toxicity after Injection of Different Coagulation Factor Concentrates. Pathophysiology of Haemostasis and Thrombosis. 19(3). 152–159. 1 indexed citations
15.
Wiman, B., et al.. (1989). The Non-covalent interaction between plasmin and α2-antiplasmin. Fibrinolysis and Proteolysis. 3(4). 231–234. 5 indexed citations
16.
Chmielewska, Joanna, et al.. (1987). On the relationship between different molecular forms of the fast inhibitor of tissue plasminogen activator. Fibrinolysis and Proteolysis. 1(2). 67–73. 32 indexed citations
17.
Wiman, B., Joanna Chmielewska, & Mats Rånby. (1984). Inactivation of tissue plasminogen activator in plasma. Demonstration of a complex with a new rapid inhibitor.. Journal of Biological Chemistry. 259(6). 3644–3647. 167 indexed citations
18.
Lijnen, Roger, B. Wiman, & D Collen. (1983). Comparison of the partial primary structure of human alpha2-antiplasmin with other plasma protease inhibitors. 2 indexed citations
19.
Lijnen, H.R., B. Wiman, B. Van Hoef, & Désiré Collen. (1982). Purification and partial primary structure of cyanogen bromide fragments from human α2-antiplasmin. Thrombosis Research. 27(1). 83–89. 2 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Victor Gurewich Breakdown of academic impact, for papers by Francisco España Breakdown of academic impact, for papers by Bradford S. Schwartz Breakdown of academic impact, for papers by H. L. Nossel Breakdown of academic impact, for papers by Jørgen Gram Breakdown of academic impact, for papers by Neal D. Tolley Breakdown of academic impact, for papers by R Bach Breakdown of academic impact, for papers by Laurent O. Mosnier Breakdown of academic impact, for papers by Ian MacGregor Breakdown of academic impact, for papers by G. P. McNicol
Rankless by CCL
2026